from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0238/-

LFCtreatmentdescriptionclass of inhibitor

-0.138

Amikacinug/mL Amikacintranslation

1.666

Cap5-10ug/mL Capreomycintranslation

1.718

Rox10-50 ug/mL Roxithromycintranslation

0.476

SM2-5 ug/mL Streptomycintranslation

0.557

Tet5-10 ug/mL Tetracyclinetranslation

-0.700

Rif0.2-5ug/mL Rifampicintranscription

-0.736

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.035

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.040

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.397

CPZ10-50 ug/mL Chlorpromazinerespiration

0.632

Clofazimine10-13 ug/mL Clofaziminerespiration

0.100

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.165

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.913

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.107

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.495

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.115

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.670

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.287

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.402

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.914

KCN5-20 ug/mL Potassium cyaniderespiration

-0.313

NaN30.2-2 mM Sodium aziderespiration

0.214

Nigericin50 uM Nigericinrespiration

-0.147

TRC10-150 ug/mL Triclosanrespiration

0.841

TRZ10-25 ug/mL Thioridazinerespiration

2.970

Valinomycin0.5-10 uM Valinomycinrespiration

1.300

ZnSO42 mM ZnSO4respiration

1.185

menadione6-10 ug/mL Menadionerespiration

-0.236

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.311

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.310

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.114

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.773

NRP_1Non-replicating persistence stage 1dosRassociated

-0.187

Amp0.2mg/mL AmpicillincellWall

-0.086

Cephalexin20-100 ug/mL CephalexincellWall

0.135

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.365

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.330

EMB10-20 ug/mL EthambutolcellWall

-0.313

Eta12-40 ug/mL EthionamidecellWall

0.292

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.018

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.496

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.115

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.150

BZA0.12 mg/mL BenzamidearomaticAmides

-0.609

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.681

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.250

H2O24 mM hydrogen peroxideDNAdamaging

-0.412

Levo10 ug/mL LevofloxacinDNAdamaging

-0.230

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.348

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.259

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.069

UVUV-irradiationDNAdamaging

-0.501

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.375

Antimycin12.5-50 ug/mL Antimycin A?

0.287

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.145

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.326

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.311

PA8240.2-2 ug/mL PA-824?

0.616

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.563

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.327

Verapamil50 uM Verapamil?

-0.777

mercaptoethanol2 mM 2-Mercaptoethanol?

0.053

methoxatin10-20 ug/mL Methoxatin?